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ABSTRACT 
Herpes Simplex Virus type 2 (HSV-2) is the leading cause of Genital Ulcer Disease (GUD) worldwide. In HIV infected persons, 
it typically presents with increased number of recurrent genital lesions which often have severe and prolonged presentations. 
There are reports that patients receiving highly active antiretroviral therapy (HAART) may be more prone to chronic genital 
ulcers and a higher risk of acyclovir-resistant herpes infection than is seen in immune competent patients. We present a case of 
recurrent genital herpes infection in a sexually active 15 year old known HIV patient. 
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RÉSUMÉ  
Herpès simplex type 2 (HSV-2) est la principale cause d'ulcérations génitales (UG) dans le monde entier. Les personnes 
infectées par le VIH, en règle générale, elle présente à l'augmentation du nombre de lésions génitales récurrentes qui ont 
souvent des présentations grave et prolongée. Il y a des rapports que les patients recevant un traitement antirétroviral 
hautement actif (HAART) peuvent être plus sujets à des ulcérations génitales chroniques et un risque plus élevé de l'infection 
d'herpès résistant à l'acyclovir qu'est vu dans l'abri les patients compétents. Nous présentons un cas d'herpès génital récurrent 
dans une infection sexuellement actif 15 ans VIH connues du patient. 
Mots-clés:  ulcère génital récurrent, HSV-2, le VIH, la multithérapie
INTRODUCTION                                                                                                             
Genital herpes is typically caused by HSV-2 but can 
also be caused by HSV-1 (1, 2). In HIV patients with 
genital herpetic ulcers, particularly those receiving 
HAART, the presentation is often more severe and 
chronic with increasing episodes of recurrent genital 
ulcers. Several reasons have been postulated 
including immune reconstitution inflammatory 
syndrome (3, 4).  It is believed that more severe 
clinical symptoms occurs following HAART due to 
the improved immune status and more effective 
ability to mount an immune response against a 
pathogen (3). 
Case Presentation     
A fifteen year old boy from an urban lower class 
setting presented to the General Out-Patient Clinic 
(GOPD) of Federal Medical Center, Abeokuta, with a 
seven (7) month history of non-healing ulcerative 
lesion affecting the penile organ.  
 




The ulcer was said to have been painful, pruritic and 
discharging serous fluid several months earlier. 
However, there was neither history of trauma to 
affected region, nor use of drugs besides prescribed 
ones. He had unprotected sexual intercourse on 
multiple occasions, two weeks before onset of the 
penile ulcer. Patient is known with vertically 
transmitted HIV infection and had been commenced 
on highly active anti-retroviral therapy (HAART) 22 
months prior to presentation. He was compliant on 
his medications up to the time of presentation. His 
past medical history was otherwise notable for 
recurrent left neck sore of two years duration.      
Patient presented afebrile and vital signs were within 
normal limits. Examination of the genitals revealed a 
non-tender, non- pruritic shallow ulcer extending 
from the lower border of his glans penis anteriorly to 
the anterolateral border of the shaft of his penis. This 
can be seen in Figure 1. All other systemic 
examinations were non-contributory.  
VDRL done at presentation was non-reactive and 
wound swab culture yielded no growth after 48hours 
of incubation, however, serology for HSV- 2 done via 
ELISA was positive in the patient and absolute CD4+ 
count was 480 cells/mm.3 He was commenced on a 10 
day course of oral Acyclovir 200mg four times daily; 
he was also prescribed acyclovir cream, erythromycin 
and his routine anti-retroviral medications. He was 
booked for regular weekly STI clinic visits. Follow up 
clinic visits showed marked improvement of ulcer 
and resolution of the wound.  
 
FIGURE 1: PENILE ULCER AT FIRST PRESENTATION 
Six months later, the patient presented to the STI 
clinic with a recurrent penile ulcer that first appeared 
as a discharging blister with associated itching and 
pain on contact three weeks earlier. The lesion was 
large, measuring about 4cm by 3cm, had no clearly 
defined edges, and was tender to touch. There was no 
inguinal lymphadenopathy.  
A diagnosis of reactivation of latent herpes simplex 
genital ulcer was subsequently made and he was 
placed on oral and topical acyclovir. He was also 
advised on good wound care and scheduled for 
follow up clinic visits. Subsequent clinic visits 
revealed increasing size of penile ulcer despite 
antiviral therapy. Patient however gave a history of 
poor drug compliance due to severe financial 
constraint. Efforts were made to ensure availability of 
drugs and proper drug compliance while patient was 
placed on acyclovir 400 mg PO daily as suppressive 
therapy. Subsequent follow up clinic visits several 
weeks later confirmed complete resolution of lesion. 
DISCUSSION 
Genital herpes, a well-recognized and globally 
endemic sexually transmitted infection (1, 2) is mostly 
as a result of HSV-2 infection (1).  However, both 
HSV-1 and HSV-2 are capable of establishing latent 
infection in the sensory root ganglion of the 
lumbosacral region with capability for subsequent 
reactivation of the disease in later time. The statistics 
for the current prevalence and incidence of HSV-2 in 
Nigeria is not well documented. However, as at 2012, 
global estimated figures revealed that 417 million 
people aged 15–49 years were living with HSV-2 
infection, of which 267 million were women (5). Also, 
19.2 million individuals aged 15–49 years were newly-
infected (5). The highest burden was in Africa (5).  
Genital Herpes typically presents as a cluster of 
painful vesicular or ulcerative muco-cutaneous 
lesions on an erythematous base. These lesions often 
crust, re-epithelialize and heal without scarring. 
Transmission typically occurs when the virus enters 
into the body through broken skin or mucous 
membranes by direct sexual contact with the 
secretions or mucosal surfaces of an infected person 
(1). The virus subsequently multiplies at the point of 
entry before ascending along the sensory nerve roots 
to the dorsal root ganglion where it establishes 
latency. Reactivation triggers the transfer of the virus 
from the dorsal root ganglion back down to the nerve 
root on the muco-cutaneous surface where it usually 
causes symptoms to occur. However, subclinical viral 
shedding has been documented in more than 80 
percent of HSV-2 seropositive persons with no 
reported lesions (6).   
Index case is a case of a 15 year old boy known with 
vertically transmitted HIV infection who presented to 
our facility on account of a seven months history of 
recurrent penile ulcer which he noticed two weeks 
after series of unprotected sexual intercourse. He was 
subsequently diagnosed serologically positive for 
HSV-2 IgG. With onset of sexual activity at age of 15 




first genital herpes infection which coincides with the 
onset of sexual activities. The history of 
immunosuppression further increases the risk of 
contracting the disease. There is a well-known 
relationship between human immunodeficiency virus 
and genital herpes infection as it has been observed 
and documented that the interaction between HSV-2 
and HIV may result in more efficient transmission of 
HIV and an increased rate of HIV replication during 
HSV-2 reactivation (6-8). 
Genital herpes in HIV infected persons typically 
presents with increased number and size of lesions 
both in primary and recurrent infections, atypical 
disease presentations and increased risk of genital 
shedding, more than is seen in immune competent 
patients (3, 4, 8). Also, the lesions are usually chronic, 
more severe and may or may not be associated with 
pain (3, 4). Studies have shown that as 
immunosuppression worsens with a drop in CD4 cell 
count, recurrent genital herpes increase in frequency, 
chronicity and severity unless interventions are made 
(3-6). Although HAART has been shown to reduce 
the duration of genital ulcers; there are reported cases 
of Immune Reconstitution Inflammatory Syndrome 
(IRIS) in HIV patients with genital herpes (3, 4, 7, 8). 
This is a paradoxical clinical worsening of an existing 
condition or the appearance of a new condition after 
initiating antiretroviral therapy in HIV-infected 
patients. 
HSV-2 is one of the most common causes of IRIS and 
HSV-2 IRIS is associated with increased severity of 
ulcerative disease and increased frequency of 
recurrences (8). Some patients present with 
worsening genital ulcers despite receiving therapy, 
this is perhaps due to excessive immune reaction to 
the infectious agent. The IRIS can occur within few 
months following the initiation of HAART. There 
should be a high index of suspicion for it in the 
presence of atypical disease presentation, treatment 
failure with standard regimen amidst improving CD4 
cell count and decreasing viral load. In this case, the 
patient’s medical history of recurrent genital ulcers, 
the background of retroviral disease on HAART, 
atypical presentation of the ulcer and failure to 
respond to standard treatment regimen helped to 
confirm the diagnosis.  
Recurrent genital herpes in HIV patients often poses a 
significant problem as patient often do not respond to 
standard treatment regimen. Acyclovir-resistant HSV 
infections are often seen and successful treatment 
with parenteral Valacyclovir, Famcyclovir and in 
some case topical corticosteroids, Imiquimod cream, 
have been reported (3, 4, 7).  Suppressive Acyclovir 
therapy at the initiation of HAART in HIV/HSV-2 co-
infected patients has been shown to blunt the 
anticipated increase in GUD incidence (8). It is worthy 
of note that an extended period of treatment with oral 
acyclovir was employed in the index case following 
failure of significant relief of symptoms after the 
standard 10 days of oral acyclovir therapy as per 
protocol. This suggests that in HIV/HSV-2 co-
infected patients and particularly those on HAART, 
acyclovir-resistance should be looked out for and 
alternative treatment initiated early. 
Conclusion: Genital herpes is frequent in HIV 
positive populations particularly those receiving 
HAART and may present with more severe, chronic 
and widespread lesions. They are more likely to be 
recurrent and be resistant to standard treatment 
regimen with oral acyclovir. Clinicians managing 
patients with HIV/HSV-2 co-infection should 
anticipate these atypical presentations and consider 
the use of suppressive acyclovir therapy or effective 
alternatives in other to reduce the severity of genital 
herpes in these patients. 
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